Novel pneumocystis antigen discovery using fungal surface proteomics

Area of Science:

• Medical Mycology
• Immunology
• Proteomics

Background:

• Pneumocystis jirovecii pneumonia (PCP) is a severe, life-threatening fungal infection primarily affecting immunocompromised individuals.
• Challenges in culturing Pneumocystis and the absence of a fully annotated genome impede the discovery of antigens for therapeutic and diagnostic development.
• Current limitations hinder the creation of effective vaccines and antibody-based treatments for PCP.

Purpose of the Study:

• To develop and validate a novel surface proteomics technique for identifying conserved antigens in Pneumocystis.
• To facilitate the discovery of novel diagnostic and therapeutic targets for Pneumocystis infections.
• To overcome limitations in organism culturing and genomic annotation for antigen discovery.

Main Methods:

• Surface proteomics analysis was performed on *Pneumocystis murina*.
• The technique reliably detected putative surface proteins conserved across *Pneumocystis* species.
• Identification of novel CD4(+) T-cell and B-cell epitopes, including the Meu10 epitope.

Main Results:

• A novel surface proteomics method was successfully established and validated.
• Putative surface proteins conserved in *Pneumocystis jirovecii* were identified.
• Novel T-cell and B-cell epitopes were discovered, including Meu10, a GPI-anchored protein involved in ascospore assembly.

Conclusions:

• The developed surface proteomics technique offers a reliable approach for identifying conserved *Pneumocystis* antigens.
• This method is expected to accelerate the discovery of novel targets for diagnostics and therapeutics against PCP.
• The findings pave the way for developing new vaccines and antibody-based interventions for *Pneumocystis* infections.